We offer specialist adult ADHD care- whether you need a diagnosis or ongoing support.
For those who think they may have ADHD and don’t have a diagnosis yet. This expanded package includes our entire range of ADHD services, including your diagnosis within a week, and your initial consultation and 2 follow ups. We offer split payments if needed.
Follow up appointments are charged at £75 per session after the first two, including repeat prescription costs.
Repeat prescriptions without a follow up cost £25 to cover admin fees.
1. Screening
2. Assessment
3. Treatment
We offer split payments if needed.
For those who think they may have ADHD and don’t have a diagnosis yet. This package includes just your diagnosis and a written report. You may opt for this if you are not interested in licensed medications, ADHD coaching, or long-term ongoing care.
1. Screening
2. Assessment
3. Receive outcome
For those who already have a diagnosis and would like ongoing care. This includes long-term management, medication reviews, and repeat prescriptions. We can prescribe licensed medications, and medical cannabis if appropriate.
Clinician + record review
Medication suitability check
Prescription (if appropriate)
Includes licensed medications + medical cannabis
Repeat prescriptions
Regular reviews
Long-term management
Apply for GP shared care when stable
1. Submit records
Fill in our online form and questionnaire
GP referral or self-referral via online form accepted
2. Review
3. Treatment
Initiating prescription + ongoing management
Two consultations
Auravia offers timely access to personal touch, high attention care. Patient wellbeing is at the core of everything we do.
We want to provide the upmost quality of care to every single patient under our care. Auravia Medical also offers the GAP scheme, providing 10% off any medicine in the UK to disadvantaged groups. Patients on an NHS waitlist also recieve priority booking of consultations.
Auravia ADHD Service is a UK-based online clinic specialising in adult ADHD. We provide the full pathway under one roof: comprehensive diagnostic assessment, medication initiation and dose optimisation (titration), and long-term ongoing care including repeat prescriptions and annual reviews. All care is delivered remotely by UK-registered clinicians with specialist ADHD experience.
We offer 3 clear pathways to potential patients, as listed at the top of this web page.
Yes. Our assessments follow the same diagnostic criteria (DSM-5) and NICE guideline NG87 that underpin in-person NHS and private assessments. Video consultation allows your clinician to take a full developmental history, observe you directly, and use validated rating scales. Many people find it easier to talk openly from their own home, and it removes travel time and waiting rooms.
Your assessment is carried out by a clinician qualified to diagnose ADHD — a consultant psychiatrist or an appropriately trained specialist clinician working within a psychiatrist-led governance framework. Prescribing during titration is managed by specialist prescribers under consultant oversight. You will be told the name and professional registration of your clinician before your appointment.
Click here to view our full list of clinicians.
Yes. We are registered with the Care Quality Commission (CQC), and all clinicians hold current registration with the GMC or NMC. Our prescribing, record-keeping and safeguarding processes are subject to regular clinical audit.
You must be aged 18 or over, resident in the UK, and registered with a UK GP. We ask every patient for their GP details — this is a safety requirement, not optional, because ADHD medications are controlled drugs and safe prescribing depends on an accurate medical history and communication with your GP.
No. As a private service you can self-refer by completing our online screening questionnaires. However, we will always write to your GP with your assessment outcome and treatment plan (with your consent) to keep your medical record complete.
Adult ADHD involves persistent inattention, impulsivity and/or hyperactivity that began in childhood and affects at least two areas of life — such as work, relationships, finances or home life. Our pre-assessment screening (including validated tools such as the ASRS) helps establish whether a full diagnostic assessment is appropriate. If screening suggests ADHD is unlikely, we will tell you honestly before you commit to the cost of an assessment.
Typically 4 weeks from booking to assessment, and 2 weeks from diagnosis to your first titration appointment. We publish current waiting times on our website and update them regularly.
Your assessment is a structured video consultation lasting around 90–120 minutes. It covers:
Where possible, we ask for an informant account — someone who knew you as a child (a parent or sibling) or knows you well now — plus school reports if you have them. These strengthen the diagnostic evidence but their absence does not prevent assessment.
You will receive a comprehensive diagnostic report, a copy of which is shared with your GP (with your consent). Your clinician will discuss treatment options with you, including medication, psychoeducation, coaching and lifestyle approaches. If you choose medication, you will be booked into our titration pathway.
A small proportion of people we assess do not meet the diagnostic threshold. If that is your outcome, your report will explain why, describe any alternative explanations for your difficulties (for example anxiety, depression, sleep disorder or trauma), and signpost appropriate next steps. An honest “no” is a core marker of a safe service.
We routinely screen for common co-occurring conditions. Where a separate formal assessment is indicated (for example autism), we will advise you and can refer or signpost accordingly.
Titration is the supervised process of starting medication at a low dose and adjusting it step by step until we find the dose that gives you the best symptom control with the fewest side effects. It typically takes 8–12 weeks, though this varies between individuals. During titration you will have regular structured reviews — usually every 2–4 weeks — where we check your symptoms, side effects, blood pressure, heart rate and weight before any dose change.
In line with NICE NG87, first-line treatment for most adults is a stimulant — lisdexamfetamine or methylphenidate. Where stimulants are unsuitable, not tolerated or not preferred, non-stimulant options such as atomoxetine may be considered. Your clinician will explain the rationale, benefits and risks of each option so the decision is made jointly with you.
Before prescribing we need a baseline physical health check: blood pressure, pulse, height and weight, plus a cardiovascular history (including family history of sudden cardiac death). Readings can be taken at a pharmacy, your GP surgery, or at home with a validated monitor. If your history suggests cardiac risk, we may ask for an ECG or GP/cardiology input first — this is a safety requirement under NICE guidance.
Common, usually mild and often transient side effects include reduced appetite, difficulty sleeping, dry mouth, headache and a small rise in heart rate or blood pressure. Your clinician will explain what to look out for and when to contact us. We monitor these actively at every titration review, and you can contact the clinical team between appointments if you are concerned.
Stimulant medications are controlled drugs because they have misuse potential outside medical supervision. Taken as prescribed, at therapeutic doses, under clinical monitoring, the risk of dependence is low — and effective treatment of ADHD is associated with reduced rates of substance misuse. We prescribe within a controlled-drug governance framework, which is why prescriptions are limited to 28–30 days and cannot be issued early without clinical review.
You are considered stable (optimised) once you and your clinician agree the dose is working well, side effects are manageable, and your physical observations are satisfactory over a sustained period. At that point you will have an end-of-titration review, and we will either continue prescribing through our ongoing care plan or approach your GP about shared care.
We issue private prescriptions electronically to our partner pharmacy, which dispenses and delivers to your door via tracked, signed-for delivery by DPD, or you can nominate a local pharmacy that accepts private electronic controlled-drug prescriptions. You pay the pharmacy directly for the cost of the medication itself.
Medication costs vary by drug, dose and pharmacy. We encourage you to compare our partner pharmacy’s price with local pharmacies. If a Shared Care Agreement is later accepted by your GP, you would pay only the standard NHS prescription charge (or nothing if exempt).
National supply problems have affected some ADHD medicines in recent years. If your medication is unavailable, do not stop abruptly without advice — contact us. Our clinicians can advise on equivalent brands or formulations, an alternative agent, or a safe bridging plan, and we track supply notifications so we can act early.
No. We can only prescribe to patients resident in the UK, and controlled drugs cannot be posted internationally. If you are travelling temporarily, see the travel section below under “Driving, Travel, and Everyday Life”. If you are relocating, we will provide a clinical summary to support transfer of your care.
Contact us as soon as possible. Because these are controlled drugs, replacement prescriptions require a clinical check and lost prescriptions or medication may require additional verification. Please order repeats at least 4 working days before you run out.
A Shared Care Agreement (SCA) is a formal arrangement between us, your GP and you. Once your dose is stable, your GP takes over routine prescribing and monitoring, while we remain responsible for specialist oversight, annual reviews, and any re-titration if your treatment needs to change. It usually means cheaper prescriptions for you (NHS charges rather than private costs).
Not necessarily, and we are transparent about this. GPs are under no obligation to accept shared care with a private provider, and many practices and Integrated Care Boards have policies declining it. We will only approach your GP once you are stable, and we provide thorough clinical documentation to support the request — but if your GP declines, we will continue prescribing privately for as long as you wish to remain with us. We recommend asking your GP practice about their shared care policy before starting treatment, so there are no surprises about long-term costs.
We strongly recommend it and it is our default, because safe prescribing of controlled drugs depends on your GP knowing what you take. If you have specific concerns about GP notification, please raise them before your assessment so we can discuss whether Auravia can safely treat you.
Medication cost is paid separately to the pharmacy.
Please scroll to the top of this web page for a full breakdown of the pathways. All fees are published on our website. There are no hidden charges, and we will never begin a chargeable stage of care without your explicit agreement.
Appointments cancelled or rearranged with more than 48 hours’ notice incur no charge. Late cancellations or missed appointments are charged because clinician time is reserved for you.
We understand ADHD itself makes appointments easy to miss — we send reminders by SMS and email at [72 and 24 hours].
You must notify the DVLA if your ADHD, or your medication, affects your ability to drive safely. A diagnosis alone does not automatically require notification — many people with well-managed ADHD drive without restriction, and treated ADHD is associated with safer driving than untreated ADHD. Your clinician will discuss driving with you at assessment and during titration, and can advise whether notification applies in your case. You should also inform your insurer if the DVLA is notified.
Usually yes, with preparation. ADHD medicines are controlled drugs and some countries restrict or prohibit them (or require import certificates), so check the rules of your destination via its embassy well in advance. Carry medication in original packaging with your prescription label, and request a travel letter from us confirming your diagnosis, medication and dose — please allow [10] working days for this. For trips over 3 months, additional export rules apply.
Moderate alcohol is not absolutely contraindicated with most ADHD medicines, but the combination can mask intoxication or worsen side effects, and alcohol the night before can blunt medication effect. Your clinician will give individual advice. Recreational drug use alongside stimulant medication is unsafe and must be discussed honestly — our role is clinical care, not judgement.
If you are pregnant, planning pregnancy or breastfeeding, tell your clinician — the risks and benefits of continuing medication need individual specialist discussion, and we will coordinate with your GP and midwifery team.
We are not an emergency or crisis service. If you are in crisis, contact NHS 111 (option 2), your GP, or attend A&E; in an emergency call 999. You can also contact the Samaritans on 116 123 at any time. Please tell us about any crisis contact so we can review your treatment plan safely.
Once stable, you move to our ongoing care plan: repeat prescriptions issued on a rolling basis subject to your monitoring checks, access to the clinical team for advice, and a full annual review of your symptoms, medication, physical health and treatment goals. If your needs change — side effects emerge, life circumstances shift, or the medication stops working as well — we can adjust your dose or re-titrate onto an alternative.
No. ADHD treatment is reviewed at least annually, and structured trial breaks can be arranged if you want to reassess whether medication is still benefiting you. Stopping should always be planned with your clinician rather than done abruptly.
Yes. You can ask your GP to refer you to your local NHS adult ADHD service (or a Right to Choose provider in England) at any point. We will provide your full clinical record and a transfer summary to support continuity. Note that NHS providers may re-review your diagnosis before taking over prescribing, and waiting lists apply.
Yes, in most cases. We will need your diagnostic report and prescribing history from your current provider. If your diagnosis was made to a recognised standard and your records are complete, we can usually continue your treatment after a transfer review appointment; if documentation is incomplete, a re-assessment may be required — we will tell you before you incur any cost.
We welcome feedback. Complaints can be raised via admin@auraviamedical.com and are acknowledged within 3 working days, with a full response within 30 working days. If you remain dissatisfied, you may escalate to the relevant ombudsman or the CQC.
